There is a trend toward a higher prevalence of antigliadin antibodies in patients with sporadic ataxia and dominant ataxia.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.